Wellinks Closed $10 Million Series B Funding from UMass Memorial Health and inside investors

Investment builds on Wellinks' strategic partnership with UMass Memorial Health and other commercial partners to accelerate growth and expand patient access to its predictive care model

NEW HAVEN, Conn., Aug. 4, 2026 /PRNewswire/ -- Wellinks, a leader in cardiopulmonary care, today announced the first close of its Series B Funding, securing $10 million to fund commercial growth with participation from UMass Memorial Health and inside investors. The investment builds on Wellinks' multiyear relationship with UMass Memorial Health and other partners to accelerate the expansion of Wellinks' predictive care solution.